Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it has sold an aggregate of 21,607,878 shares of the ...

abrdn Healthcare Investors Q1 2026 Commentary

Healthcare Investors lagged its benchmark as biotech faced regulatory hurdles and market rotation. Read the full analysis for ...

Edesa Biotech, Inc.: Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results

Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases ...
National Hog Farmer

Disease, trade and market power: Volatile stretch for pork policy

Pseudorabies detection triggers restrictions; Trump–Xi summit is driving expectations; Antitrust investigation into beef ...

Gedeon Richter PLC (GEDSF) Q1 2026 Earnings Call Transcript

Q1 2026 Earnings Call May 11, 2026 8:00 PM EDTCompany ParticipantsRobert Rethy - Head of the Investor Relations & ...

Here are Friday's biggest analyst calls: Nvidia, Alphabet, Dell, Cisco, Netflix, Texas Roadhouse, J.M. Smucker & more

Stifel upgrades RXO to buy from hold Stifel said its sees "idiosyncratic levers" for the asset-light transportation company. ...

Calidi Biotherapeutics, Inc: Calidi Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Operational Highlights

Presented new data on CLD-401 at the AACR conference in San Diego, CA, detailing the profound immune changes in the tumor microenvironment induced by CLD-401; IND filing for CLD-401 expected by end of ...